Patients with advanced colorectal cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Rectum HT29 Cells Colon Cell Line, Tumor HCT116 Cells Intestinal Mucosa Tumor Cells, Cultured Hepatic Artery Caco-2 Cells Neoplastic Stem Cells

Organisms1

Diseases46

Colorectal Neoplasms Rectal Neoplasms Colonic Neoplasms Adenocarcinoma Neoplasm Metastasis Adenoma Disease Progression Liver Neoplasms Carcinoma Stomatitis Diarrhea Colorectal Neoplasms, Hereditary Nonpolyposis Colonic Polyps Nausea Neutropenia Neoplasm Recurrence, Local Leukopenia Neoplasm Invasiveness Microsatellite Instability Adenomatous Polyps Genetic Predisposition to Disease Adenomatous Polyposis Coli Lung Neoplasms Lymphatic Metastasis Intestinal Polyps Neoplasms Breast Neoplasms Stomach Neoplasms Prostatic Neoplasms Gastrointestinal Neoplasms Ovarian Neoplasms Cell Transformation, Neoplastic Adenocarcinoma, Mucinous Pancreatic Neoplasms Precancerous Conditions Sigmoid Neoplasms Rectal Diseases Neoplasms, Multiple Primary Endometrial Neoplasms Vomiting Uterine Cervical Neoplasms Neoplastic Syndromes, Hereditary Chromosomal Instability Neovascularization, Pathologic Carcinoma, Squamous Cell Colonic Diseases

Chemicals and Drugs64

Fluorouracil Leucovorin Organoplatinum Compounds Camptothecin Antimetabolites, Antineoplastic Thiophenes Antibodies, Monoclonal, Humanized Thymidylate Synthase Deoxycytidine Antineoplastic Agents ras Proteins Antibodies, Monoclonal Antineoplastic Agents, Phytogenic Tegafur Antidotes Tumor Markers, Biological Trimetrexate Quinazolines Levoleucovorin Proto-Oncogene Proteins B-raf Carcinoembryonic Antigen Uracil Oxonic Acid Receptor, Epidermal Growth Factor Proto-Oncogene Proteins Angiogenesis Inhibitors Phthalazines Lentinan Mitomycin Phosphonoacetic Acid Glucuronosyltransferase Methotrexate Interferon-alpha Neoplasm Proteins Drug Combinations MutS Homolog 2 Protein DNA, Neoplasm Antibodies, Anti-Idiotypic One-Carbon Group Transferases Pyridines Semustine Vascular Endothelial Growth Factor A Floxuridine beta Catenin RNA, Messenger Adaptor Proteins, Signal Transducing Recombinant Proteins Tumor Suppressor Protein p53 Nuclear Proteins Adenomatous Polyposis Coli Protein Cancer Vaccines DNA-Binding Proteins Cyclooxygenase 2 Prodrugs Barium Sulfate Antigens, Neoplasm Anticarcinogenic Agents Anti-Inflammatory Agents, Non-Steroidal RNA, Small Interfering Tumor Suppressor Proteins Carrier Proteins Keratin-20 MicroRNAs RNA, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Infusions, Intravenous Survival Analysis Neoplasm Staging Colonoscopy Disease-Free Survival Survival Rate Prognosis Clinical Trials, Phase III as Topic Early Detection of Cancer Pelvic Exenteration Prospective Studies Palliative Care Maximum Tolerated Dose Occult Blood Retrospective Studies Sigmoidoscopy Injections, Intravenous Follow-Up Studies Randomized Controlled Trials as Topic Administration, Oral Drug Evaluation Kaplan-Meier Estimate Salvage Therapy Immunohistochemistry Predictive Value of Tests Risk Factors DNA Mutational Analysis Multivariate Analysis Combined Modality Therapy Risk Assessment Case-Control Studies Clinical Trials as Topic Chemotherapy, Adjuvant Mass Screening Cohort Studies Remission Induction Clinical Trials, Phase II as Topic Proportional Hazards Models Treatment Failure Sensitivity and Specificity Odds Ratio Risk Colectomy Reverse Transcriptase Polymerase Chain Reaction Incidence Logistic Models Area Under Curve Registries Questionnaires Polymerase Chain Reaction Confidence Intervals Colonography, Computed Tomographic Infusions, Intra-Arterial Gene Expression Profiling Genetic Testing Xenograft Model Antitumor Assays Blotting, Western Enema Neoplasm Transplantation Immunoenzyme Techniques Pilot Projects Tissue Array Analysis Tomography, X-Ray Computed Transplantation, Heterologous Oligonucleotide Array Sequence Analysis Reproducibility of Results Biopsy, Needle SEER Program Patient Selection Tumor Burden Chemoprevention Hepatectomy Multicenter Studies as Topic Neoplasm Grading Molecular Targeted Therapy

Psychiatry and Psychology1

Phenomena and Processes46

Dose-Response Relationship, Drug Drug Resistance, Neoplasm Maximum Tolerated Dose Gene Expression Regulation, Neoplastic Mutation Time Factors Polymorphism, Genetic Genes, ras Microsatellite Instability Genetic Predisposition to Disease Microsatellite Repeats DNA Methylation Genotype Drug Synergism Sensitivity and Specificity Odds Ratio Germ-Line Mutation DNA Mismatch Repair Risk Genes, APC Area Under Curve Base Pair Mismatch Cell Proliferation CpG Islands Apoptosis Polymorphism, Single Nucleotide Diet Promoter Regions, Genetic Loss of Heterozygosity Genes, p53 Alleles Phenotype Genes, DCC Down-Regulation DNA Repair Signal Transduction Gene Silencing Genes, Tumor Suppressor Cell Movement Up-Regulation Base Sequence Cell Survival Cell Division Chromosomal Instability Polymorphism, Single-Stranded Conformational Genes, Neoplasm

Disciplines and Occupations3

Immunohistochemistry Colorectal Surgery Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science6

Survival Rate Incidence Registries Questionnaires SEER Program Base Sequence

Named Groups3

Survivors Asian Continental Ancestry Group European Continental Ancestry Group

Health Care41

Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate Clinical Trials, Phase III as Topic Prospective Studies Palliative Care Retrospective Studies Follow-Up Studies Randomized Controlled Trials as Topic Kaplan-Meier Estimate Predictive Value of Tests Risk Factors Multivariate Analysis Risk Assessment Case-Control Studies Clinical Trials as Topic Mass Screening Cohort Studies Clinical Trials, Phase II as Topic Proportional Hazards Models Treatment Failure Sensitivity and Specificity Odds Ratio Risk Incidence Logistic Models Area Under Curve Registries Questionnaires Confidence Intervals Age Factors Genetic Testing Pilot Projects Reproducibility of Results SEER Program Patient Selection Sex Factors Multicenter Studies as Topic National Cancer Institute (U.S.)Family Health

Geographicals3

Japan United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Colorectal Neoplasms Fluorouracil Leucovorin Organoplatinum Compounds Camptothecin Antineoplastic Combined Chemotherapy Protocols Antimetabolites, Antineoplastic Rectal Neoplasms Drug Administration Schedule Treatment Outcome Colonic Neoplasms Adenocarcinoma Infusions, Intravenous Thiophenes Antibodies, Monoclonal, Humanized Survival Analysis Neoplasm Metastasis Thymidylate Synthase Neoplasm Staging Colonoscopy Disease-Free Survival Deoxycytidine Adenoma Survival Rate Disease Progression Antineoplastic Agents ras Proteins Prognosis Liver Neoplasms Antibodies, Monoclonal Antineoplastic Agents, Phytogenic Tegafur Antidotes Carcinoma Tumor Markers, Biological Trimetrexate Clinical Trials, Phase III as Topic Early Detection of Cancer Quinazolines Stomatitis Levoleucovorin Diarrhea Colorectal Neoplasms, Hereditary Nonpolyposis Pelvic Exenteration Prospective Studies Proto-Oncogene Proteins B-raf Carcinoembryonic Antigen Dose-Response Relationship, Drug Colonic Polyps Nausea Drug Resistance, Neoplasm Palliative Care Maximum Tolerated Dose Uracil Occult Blood Retrospective Studies Oxonic Acid Gene Expression Regulation, Neoplastic Mutation Sigmoidoscopy Injections, Intravenous Neutropenia Receptor, Epidermal Growth Factor Proto-Oncogene Proteins Follow-Up Studies Angiogenesis Inhibitors Phthalazines Time Factors Neoplasm Recurrence, Local Randomized Controlled Trials as Topic Administration, Oral Drug Evaluation Kaplan-Meier Estimate Salvage Therapy Lentinan Immunohistochemistry Polymorphism, Genetic Rectum Genes, ras Mitomycin Phosphonoacetic Acid Predictive Value of Tests Leukopenia Risk Factors DNA Mutational Analysis Multivariate Analysis Glucuronosyltransferase Quality of Life Combined Modality Therapy Risk Assessment Methotrexate Case-Control Studies Interferon-alpha Japan Clinical Trials as Topic Chemotherapy, Adjuvant Mass Screening Neoplasm Invasiveness Cohort Studies HT29 Cells

No FAQ available that match "patients with advanced colorectal cancer"